ArticleJournal of applied gerontology : the official journal of the Southern Gerontological Society2026
Structural Vulnerability and the Pandemic: Widening Gaps in Nursing Home Antipsychotic Prescribing.
Article in Journal of applied gerontology : the official journal of the Southern Gerontological Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
To assess whether national reductions in antipsychotic prescribing in U.S. nursing homes were shared equitably or masked widening gaps between top and bottom performers, we examined distributional trends across facilities from 2013 to 2023 using national facility-level data (CMS Provider Data Catalog; LTCFocus). We modeled long-stay antipsychotic measure performance using linear quantile mixed regression, assessed mobility across performance quartiles with transition matrices, and evaluated facility characteristics associated with trajectories. From 2013 to 2019, prescribing fell across all quantiles, with the steepest reductions among the worst performers, narrowing gaps with the best. After 2020, progress diverged: lower-performing facilities experienced sharp setbacks while top performers maintained gains. Mobility analyses showed entrenched disadvantage, with bottom-quartile facilities disproportionately likely to remain there. Higher Medicaid share predicted decline, whereas higher star ratings predicted improvement. The pandemic reversed earlier equity gains, amplifying structural disparities and exposing unequal capacity to sustain improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.